These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Magnetic resonance spectroscopy of the cervical cord in amyotrophic lateral sclerosis. Carew JD; Nair G; Pineda-Alonso N; Usher S; Hu X; Benatar M Amyotroph Lateral Scler; 2011 May; 12(3):185-91. PubMed ID: 21143004 [TBL] [Abstract][Full Text] [Related]
3. Effect of creatine supplementation on metabolite levels in ALS motor cortices. Vielhaber S; Kaufmann J; Kanowski M; Sailer M; Feistner H; Tempelmann C; Elger CE; Heinze HJ; Kunz WS Exp Neurol; 2001 Dec; 172(2):377-82. PubMed ID: 11716561 [TBL] [Abstract][Full Text] [Related]
4. Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy. Kalra S; Hanstock CC; Martin WR; Allen PS; Johnston WS Arch Neurol; 2006 Aug; 63(8):1144-8. PubMed ID: 16908742 [TBL] [Abstract][Full Text] [Related]
5. Role of diffusion tensor imaging or magnetic resonance spectroscopy in the diagnosis and disability assessment of amyotrophic lateral sclerosis. Liu C; Jiang R; Yi X; Zhu W; Bu B J Neurol Sci; 2015 Jan; 348(1-2):206-10. PubMed ID: 25524526 [TBL] [Abstract][Full Text] [Related]
6. β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS. de Munck E; Muñoz-Sáez E; Miguel BG; Solas MT; Ojeda I; Martínez A; Gil C; Arahuetes RM Environ Toxicol Pharmacol; 2013 Sep; 36(2):243-255. PubMed ID: 23688553 [TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Pohl C; Block W; Karitzky J; Träber F; Schmidt S; Grothe C; Lamerichs R; Schild H; Klockgether T Arch Neurol; 2001 May; 58(5):729-35. PubMed ID: 11346367 [TBL] [Abstract][Full Text] [Related]
8. Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis. Atassi N; Xu M; Triantafyllou C; Keil B; Lawson R; Cernasov P; Ratti E; Long CJ; Paganoni S; Murphy A; Salibi N; Seethamraju R; Rosen B; Ratai EM PLoS One; 2017; 12(5):e0177680. PubMed ID: 28498852 [TBL] [Abstract][Full Text] [Related]
10. Study of the features of proton MR spectroscopy ((1)H-MRS) on amyotrophic lateral sclerosis. Han J; Ma L J Magn Reson Imaging; 2010 Feb; 31(2):305-8. PubMed ID: 20099342 [TBL] [Abstract][Full Text] [Related]
11. Motor cortex metabolite alterations in amyotrophic lateral sclerosis assessed in vivo using edited and non-edited magnetic resonance spectroscopy. Weerasekera A; Peeters R; Sima D; Dresselaers T; Sunaert S; De Vocht J; Claeys K; Van Huffel S; Van Damme P; Himmelreich U Brain Res; 2019 Sep; 1718():22-31. PubMed ID: 31002818 [TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging and magnetic resonance spectroscopy in a patient with amyotrophic lateral sclerosis and frontotemporal dementia. Sarac H; Zagar M; Vranjes D; Henigsberg N; Bilić E; Pavlisa G Coll Antropol; 2008 Jan; 32 Suppl 1():205-10. PubMed ID: 18405084 [TBL] [Abstract][Full Text] [Related]
13. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Wang S; Poptani H; Woo JH; Desiderio LM; Elman LB; McCluskey LF; Krejza J; Melhem ER Radiology; 2006 Jun; 239(3):831-8. PubMed ID: 16641339 [TBL] [Abstract][Full Text] [Related]
14. Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis. Pyra T; Hui B; Hanstock C; Concha L; Wong JC; Beaulieu C; Johnston W; Kalra S Amyotroph Lateral Scler; 2010; 11(1-2):157-65. PubMed ID: 19242831 [TBL] [Abstract][Full Text] [Related]
15. Spinal cord infusion of stem cells in amyotrophic lateral sclerosis: Magnetic resonance spectroscopy shows metabolite improvement in the precentral gyrus. García Santos JM; Inuggi A; Gómez Espuch J; Vázquez C; Iniesta F; Blanquer M; María Moraleda J; Martínez S Cytotherapy; 2016 Jun; 18(6):785-96. PubMed ID: 27173751 [TBL] [Abstract][Full Text] [Related]
16. MR spectroscopy evaluation and short-term outcome of olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients. Huang H; Tan K; Chen L; Xue Y; Wang H; Xi H; Liu Y; Zhang F; Zhang J Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Jan; 21(1):52-7. PubMed ID: 17305006 [TBL] [Abstract][Full Text] [Related]
17. Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS. Carew JD; Nair G; Andersen PM; Wuu J; Gronka S; Hu X; Benatar M Neurology; 2011 Oct; 77(14):1370-5. PubMed ID: 21940617 [TBL] [Abstract][Full Text] [Related]
18. Diffusion tensor MRI and MR spectroscopy in long lasting upper motor neuron involvement in amyotrophic lateral sclerosis. Lombardo F; Frijia F; Bongioanni P; Canapicchi R; Minichilli F; Bianchi F; Hlavata H; Rossi B; Montanaro D Arch Ital Biol; 2009 Sep; 147(3):69-82. PubMed ID: 20014653 [TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Block W; Karitzky J; Träber F; Pohl C; Keller E; Mundegar RR; Lamerichs R; Rink H; Ries F; Schild HH; Jerusalem F Arch Neurol; 1998 Jul; 55(7):931-6. PubMed ID: 9678310 [TBL] [Abstract][Full Text] [Related]
20. Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis. Abe K; Takanashi M; Watanabe Y; Tanaka H; Fujita N; Hirabuki N; Yanagihara T Neuroradiology; 2001 Jul; 43(7):537-41. PubMed ID: 11512581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]